Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

USC turns immune progenitors into renewable cancer-fighting cells

USC researchers engineered renewable immune progenitors that generate cancer-fighting cells in mice and may support off-the-shelf immunotherapy.

WHO and ASCO have formalized a cancer care partnership focused on workforce training, clinical trial access, and better-quality…

A JCI review explains how PI3K drives breast cancer, why inhibitors work in selected patients, and how adaptive…

A JCI review details how next-generation SERDs target ER-positive breast cancer, ESR1 mutations, and the tumor immune microenvironment.

Darolutamide plus ADT delayed pain progression and quality-of-life decline in metastatic hormone-sensitive prostate cancer in ARANOTE.

US oncology cases show how evidence moved into policy and care through legislation, payment reform, advocacy, and financial…

A Nature Reviews Clinical Oncology review frames pCR, ctDNA, radiomics, and biomarkers as tools to refine perioperative treatment…

A Nature Reviews Clinical Oncology review traces how CRISPR is entering cancer diagnostics, functional genomics, and early therapeutic…

A PLOS ONE study found an XGBoost model using four routine predictors offered moderate accuracy for preoperative lymph…

In renal and other cancers, non-exonic read fraction distorted lncRNA co-expression networks and weakened prognostic value in a…

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds